top of page
Browse by category
Search


Weight loss drugs pose challenges for plastic surgeons
The popularity of GLP-1 drugs has created a new generation of body contouring patients and a new set of challenges for plastic surgeons, according to a study from Duke University School of Medicine, which suggests that how much weight patients lose - and how fast - could affect surgical results to tighten or remove excess skin after massive weight loss. The study found that massive or rapid weight loss prior to abdominal body contouring surgery is predictive of postoperative


Journal Watch 15/05/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Dose-dependent link between the use of semaglutide and liraglutide injectables and body contouring procedures
There is a dose-dependent link between the use of injectable glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide and...


Journal Watch 25/10/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Bariatric patients regain more weight than non-bariatric patients after body contouring surgery
Patients with previous bariatric surgery who undergo body contouring (BC) regain more weight at long-term follow-up, compared to body...


Body contouring does not offer clinically significant, long-term sustained weight loss benefit
For patients with massive weight loss after bariatric surgery, subsequent body contouring to remove excess skin is not itself associated...


Body contouring significantly improves outcomes for patients
Body contouring procedures following bariatric surgery leads to significant improvements in both the psychological and social aspects of...
Browse by tag






bottom of page
